Reply
vishvesh.shaishav@gmail.com
We are focussed on developing new manufacturing technologies, including custom synthesis of new moleculepharma intermediate, catalyst, bulk drugs, pharma API, pharma chemicals, active pharmaceutical ingredients, pharmaceutical pellets,additives, contract manufacturing, chemicals. We began in the field of specialty intermediates for pharmaceutical applications and developed our own purification technologies for manufacturing highly pure intermediates. And Pharmaceutical API At a later stage, we integrated forward to manufacture finished formulations for both veterinary and human consumption. Due to our completely integrated operations in the pharmaceutical sector, we continuously learn about the quality parameters for an API based on the performance of the finished formulation in order to quality their Bioequivalence Studies.
We have established finished formulation lines in South Asian and Latin American countries. It is our vision to achieve worldwide recognition as an excellent business partner from India by providing our customers with superior quality products at highly affordable prices and following that up with reliable service consistently, thereby giving them an unparalleled experience.
Our focus lies in developing new production technologies with a keen interest in frugal innovation in order to gain a competitive edge over others. We specialize in the custom synthesis of molecules and work with many reputed companies around the world on an OEM basis.pharmaceutical pellets,Intermidiates
Our finished formulations from WHO-GMP and EU-GMP units are registered/being registered in 26 countries within Asia, Europe, North America, Latin America and Africa continents including Peru, Panama, Ecuador, Chile, Curaçao, Suriname, Haiti, Aruba, Trinidad, Tobago, Philippines, Myanmar, Laos, Malaysia, Thailand, Indonesia, Hong Kong, Vietnam, Sri Lanka, Maldives, Brunei, Nepal, China, Russia, Croatia, Venezuela and Bhutan.
vishvesh.shaishav@gmail.com
alicechan@huarizy.com
HUNAN HUARI PHARMACEUTICAL CO.,LTD. is the Chinese manufacturer for the following APIs and excipients, please feel free to contact us if you have any requirements.
1) Citric acid Monohydrate GMP
2) Citric acid Anhydrous GMP
3) Sodium citrate GMP
4) Potassium Citrate GMP
5) Sodium benzoate
6) Stearic acid
7) Sodium cyclamate
8) Potassium Sorbate
9) Polysorbate 80
email address: alicechan@huarizy.com
phone number: +86 18820220687
support@carense.com
At Carense we see the ability to provide creative and innovative solutions to regulatory challenges as an integral part of our offering in providing custom solutions to innovative companies. We’ve used our extensive regulatory experience to work with our customers and to develop effective ways to manage multi-filings in multiple territories for example. It’s all part of providing a holistic service offering that’s designed to broadly support customers for their CMC requirements.
There is increasing demand for broad-based service providers who can provide customers with an extensive range of offerings. As such, Carense now provides an integral API service for sourcing and development, by bringing these capabilities together with our existing expertise in this space and our process development capabilities, we can provide customers with a more simplified and complete offering.
=================================
Carense Ltd
71-75 Shelton Street
London,
WC2H 9JQ
United Kingdom
Company No. 12378533
Telephone: 0208 945 3443
Email: support@carense.com
=================================
eckebeto@justiupharm.com
Greetings,
We are Xinganjiang Pharmaceutical Co., Ltd., a comprehensive pharmaceutical enterprise established in 2004 in Jiangxi province, China.
We are pleased to inform you that we manufacture a range of pharmaceutical products, including Calcium Gluconate, Zinc Gluconate, Ferrous Gluconate, Dimercaptosuccinic Acid, Stanozolol, and Dexamethasone Sodium Phosphate.
Our products are manufactured in compliance with CP, USP, and BP standards, ensuring the highest quality.
